Search results for “SCLC - Small cell lung cancer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 629 patents, we discovered top 193 key players by total patent application. AstraZeneca Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., MedImmune Ltd. are dominant in this area. They take 12.72% of the total patent filing.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 32
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 28
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 20
Genentech, Inc.
California, United States
Patent: 18
Novartis AG
Basel-Stadt, Switzerland
Patent: 17
Eli Lilly & Co.
Indiana, United States
Patent: 17
Abraxis BioScience LLC
California, United States
Patent: 17
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 15
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 14
Merck Patent GmbH
Hessen, Germany
Patent: 14
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 13 patents, we discovered top 8 start-ups by total patent application. OrigiMed (Shanghai) Co., Ltd., Wellmarker Bio Co., Ltd., Bluefin Biomedicine, Inc. are active in this area.
STARTUP
OrigiMed (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 4
STARTUP
Wellmarker Bio Co., Ltd.
South Korea
Patent: 2
STARTUP
Bluefin Biomedicine, Inc.
Massachusetts, United States
Patent: 2
STARTUP
SERVIER PHARMA LLC
Massachusetts, United States
Patent: 1
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
STARTUP
Inivata Ltd.
Massachusetts, United States
Patent: 1
STARTUP
Luxna Biotech Co. Ltd.
Osaka-fu, Japan
Patent: 1
STARTUP
KLUS Pharma, Inc.
New Jersey, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 620 patents applied in the last 5 years. We discover 270 most active companies in this area. The fast-growing AstraZeneca Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Shenzhen Chipscreen Biosciences Co., Ltd. take 10.81% of patent filing during this period.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 32
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 20
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 15
Merck Patent GmbH
Hessen, Germany
Patent: 12
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 12
Genentech, Inc.
California, United States
Patent: 11
Bristol Myers Squibb Co.
New York, United States
Patent: 10
Cancer Hospital Chinese Academy of Medical Sciences
Beijing Shi, China
Patent: 9
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 9
Shanghai Junshi Biosciences Co., Ltd.
Shanghai Shi, China
Patent: 9
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 620 patents in last 5 years, we discover 227 new entrants. AstraZeneca Pharmaceutical Co., Ltd., Shenzhen Chipscreen Biosciences Co., Ltd., Iovance Biotherapeutics, Inc. are the most active new entrants in this area.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 32
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 15
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 12
Bristol Myers Squibb Co.
New York, United States
Patent: 10
Cancer Hospital Chinese Academy of Medical Sciences
Beijing Shi, China
Patent: 9
Shanghai Junshi Biosciences Co., Ltd.
Shanghai Shi, China
Patent: 9
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 8
Regents of the University of California
California, United States
Patent: 7
Shandong First Medical University
Shandong Sheng, China
Patent: 7
Inventisbio Shanghai Ltd
Shanghai Shi, China
Patent: 7
Research Institutions
Order by:
Innovation Intensity
With the analysis among 224 patents, we discovered top 98 universities and scientific research institutions by total patent application. China Pharmaceutical University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of British Columbia are dominant in this area. They take 10.27% of the total patent filing.
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 6
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 6
University of British Columbia
British Columbia, Canada
Patent: 5
Fudan University
Shanghai Shi, China
Patent: 5
Shanghai University
Shanghai Shi, China
Patent: 5
Cornell University
New York, United States
Patent: 4
The Rockefeller University
New York, United States
Patent: 3
University of Tokyo
Tokyo-to, Japan
Patent: 3
Zhejiang University
Zhejiang Sheng, China
Patent: 3
Wenzhou Medical College
Zhejiang Sheng, China
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: